Potomac Analytics' Logo

Broker-Dealers on SEC Form D for GOLDMAN, SACHS & CO.

Form Ds provide information on individual, unregistered securities offerings.

Search by Recipient Name or Primary Issuer:

Filter by:

Sort by:

Displaying 1,271-1,280 out of 3,450 results
Recipient CRD Primary Issuer CIK Filing Date Form Type Total Offering Amount Total Amount Sold
GOLDMAN, SACHS & CO.361Workhorse Group Inc.142528710/28/2020D$200,000,000$200,000,000
GOLDMAN, SACHS & CO.361Nautilus Biotechnology, Inc.180880506/22/2021D$200,000,000$200,000,000
GOLDMAN, SACHS & CO.361Private Equity Managers (2020) LP179865401/03/2020DIndefinite$199,895,000
GOLDMAN, SACHS & CO.361First Pacific: Dynamic Equity Opportunities LLC153906009/22/2014D/AIndefinite$199,734,000
GOLDMAN, SACHS & CO.361Private Credit Managers III Offshore LP181741807/13/2020DIndefinite$199,190,000
GOLDMAN, SACHS & CO.361SLR Healthcare Access LLC183582512/10/2020DIndefinite$198,450,000
GOLDMAN, SACHS & CO.361Private Equity Managers (2016) LP166645502/11/2016DIndefinite$196,460,000
GOLDMAN, SACHS & CO.361YC Holdings LLC146819907/20/2009D$205,000,000$195,000,000
GOLDMAN, SACHS & CO.361Kinesis Holdings I Ltd162417112/30/2015DIndefinite$194,725,976
GOLDMAN, SACHS & CO.361Altrinsic: Non-US Equity LLC141901406/07/2011D/AIndefinite$194,193,269

3,450 Results

Display: